The Experts below are selected from a list of 1407 Experts worldwide ranked by ideXlab platform
Marcel D Waldinger - One of the best experts on this subject based on the ideXlab platform.
-
Disorders of Orgasm and Ejaculation in Menjsm_1782 1668..1686
2016Co-Authors: David Rowl, Chris G Mcmahon, Marcel D Waldinger, Carmita Abdo, Juza Chen, Emmanuele Jannini, Tai Young AhnAbstract:Introduction. Ejaculatory/orgasmic disorders are common male sexual dysfunctions, and include premature ejacu-lation (PE), inhibited ejaculation, anejaculation, retrograde ejaculation, and Anorgasmia. Aim. To provide recommendations and guidelines concerning current state-of-the-art knowledge for management of ejaculation/orgasmic disorders in men. Methods. An international consultation in collaboration with the major urology and sexual medicine association
-
Summary of Committee. For the complete report please refer to Sexual Medicine: Sexual Dysfunctions in Men and
2013Co-Authors: Michael A Perelman, Marcel D Waldinger, David Rowl, Zhong Cheng Xin, Edited T. F. Lue, R. Basson, R. Rosen, F. Giuliano, S. Khoury, F. MontorsiAbstract:Introduction. Ejaculatory/orgasmic disorders, common male sexual dysfunctions, include premature ejaculation, inhibited ejaculation, anejaculation, retrograde ejaculation and Anorgasmia. Aim. To provide recommendations/guidelines concerning state-of-the-art knowledge for management of ejaculation/orgasmic disorders in men. Methods. An International Consultation in collaboration with the major urology and sexual medicin
-
original researchdisorders of orgasm and ejaculation in men
The Journal of Sexual Medicine, 2004Co-Authors: Chris G Mcmahon, Carmita Helena Najjar Abdo, Luca Incrocci, Michael A Perelman, David L Rowland, Marcel D WaldingerAbstract:Introduction Ejaculatory/orgasmic disorders, common male sexual dysfunctions, include premature ejaculation, inhibited ejaculation, anejaculation, retrograde ejaculation and Anorgasmia.
-
Use of Psychoactive Agents in the Treatment of Sexual Dysfunction
CNS Drugs, 1996Co-Authors: Marcel D WaldingerAbstract:Sexual function can be subdivided into phases of sexual desire, penile erection, ejaculation and orgasm. Dysfunction of these processes is manifest as disorders that include hypoactive sexual desire, male erectile dysfunction, premature and retarded ejaculation, and Anorgasmia. These disorders can be primary in aetiology or can be caused by a number of psychoactive drugs including, commonly, antidepressants. At present, sexual dysfunction is rarely treated with pharmacological agents. The usual approach consists of psychotherapy. However, in recent years, more interest has arisen in treating disorders of sexual function with psychopharmacological drugs, particularly sexual dysfunction that is the adverse effect of antidepressants. Clinical reports suggest that primary premature ejaculation can be successfully treated with clomipramine and selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors. At present, only a few oral medications have been shown to be useful in the treatment of erectile dysfunction (including yohimbine and trazodone), although these have not been developed specifically for this indication. The pharmacological treatment of primary retarded ejaculation and female primary Anorgasmia still offers no efficacy. There are, on the other hand, a number of drugs available for treating the sexual adverse effects of antidepressant therapy. These appear to act either on the central or peripheral nervous system and include cyproheptadine, bethanechol, yohimbine, buspirone and some dopamine receptor agonists [amantadine, amfebutamone (bupropion), dexamphetamine and pemoline]. More methodologically correct clinical research is necessary to elucidate better treatments for sexual dysfunction.
-
Use of Psychoactive Agents in the Treatment of Sexual Dysfunction
CNS Drugs, 1996Co-Authors: Marcel D WaldingerAbstract:Sexual function can be subdivided into phases of sexual desire, penile erection, ejaculation and orgasm. Dysfunction of these processes is manifest as disorders that include hypoactive sexual desire, male erectile dysfunction, premature and retarded ejaculation, and Anorgasmia. These disorders can be primary in aetiology or can be caused by a number of psychoactive drugs including, commonly, antidepressants.
N. Salehi - One of the best experts on this subject based on the ideXlab platform.
-
318 – The study of causes of the psychological and pharmacological Anorgasmia in affected women in ardabil
European Psychiatry, 2013Co-Authors: E. Rezaei Ghalechi, R. Kazemi, M. Pirzadeh, N. SalehiAbstract:Introduction Women's mental health is important factor for life of societies. Objectives Many factors affect orgasmic function, age, education, job, folklore (taboos) religious beliefs, drugs, psychological disorders and gynecological surgery. Aims Our main goal was the study of causes of the psychological and pharmacological of Anorgasmia in affected women in Ardabil. Methods The present study is a descriptive-cross sectional one. a total of 500 married women were selected and they completed the demographic and female sexual function index (FSFI) questionnarie.orgasm was assessed according to the relevant questions in the FSFI questionnaire.122 women were anorgasmic and they completed the SCL-90 questionnaire. The data were analyzed using the statistical software SPSS and the descriptive statistics (frequency-percent) and the deductive statistics (Correlation-t test). P value Results The prevalence of Anorgasmia among women in Ardabil was 24.4% and the average age of th anorgasmic women was 31.1%. The relation between the obsession -compulsion disorder and the Anorgasmia with P=0.000 was meaningful. The relation of depression with P=0.91 and using the SSRI drugs with P=0.28 and using the three cyclic anti-depression drugs with P=0.09 and using the ACE-I drugs with P=0.63 with the Anorgasmia wasn’t meaningful. Conclusion The prevalence of Anorgasmia in Ardabil women is at its high level and psychological factors influence this disorder so the diagnosis of this disorder and control of effective factors will help reducing of family fade and its impacts on society.
-
318 the study of causes of the psychological and pharmacological Anorgasmia in affected women in ardabil
European Psychiatry, 2013Co-Authors: Rezaei E Ghalechi, R. Kazemi, M. Pirzadeh, N. SalehiAbstract:Introduction Women's mental health is important factor for life of societies. Objectives Many factors affect orgasmic function, age, education, job, folklore (taboos) religious beliefs, drugs, psychological disorders and gynecological surgery. Aims Our main goal was the study of causes of the psychological and pharmacological of Anorgasmia in affected women in Ardabil. Methods The present study is a descriptive-cross sectional one. a total of 500 married women were selected and they completed the demographic and female sexual function index (FSFI) questionnarie.orgasm was assessed according to the relevant questions in the FSFI questionnaire.122 women were anorgasmic and they completed the SCL-90 questionnaire. The data were analyzed using the statistical software SPSS and the descriptive statistics (frequency-percent) and the deductive statistics (Correlation-t test). P value Results The prevalence of Anorgasmia among women in Ardabil was 24.4% and the average age of th anorgasmic women was 31.1%. The relation between the obsession -compulsion disorder and the Anorgasmia with P=0.000 was meaningful. The relation of depression with P=0.91 and using the SSRI drugs with P=0.28 and using the three cyclic anti-depression drugs with P=0.09 and using the ACE-I drugs with P=0.63 with the Anorgasmia wasn’t meaningful. Conclusion The prevalence of Anorgasmia in Ardabil women is at its high level and psychological factors influence this disorder so the diagnosis of this disorder and control of effective factors will help reducing of family fade and its impacts on society.
H. Lauerma - One of the best experts on this subject based on the ideXlab platform.
-
Successful treatment of citalopram‐induced Anorgasmia by cyproheptadine
Acta Psychiatrica Scandinavica, 1996Co-Authors: H. LauermaAbstract:This is the first report of the use of cyproheptadine to treat Anorgasmia induced by citalopram, a highly selective serotonine reuptake inhibitor (SSRI). Total Anorgasmia of a 47 year-old man who suffered from severe unipolar major depression was successfully treated without adverse effects. This case strengthens the impression that Anorgasmia associated with SSRIs is related primarily to the serotonine reuptake inhibition and not to various receptor bindings of different compounds.
-
successful treatment of citalopram induced Anorgasmia by cyproheptadine
Acta Psychiatrica Scandinavica, 1996Co-Authors: H. LauermaAbstract:This is the first report of the use of cyproheptadine to treat Anorgasmia induced by citalopram, a highly selective serotonine reuptake inhibitor (SSRI). Total Anorgasmia of a 47 year-old man who suffered from severe unipolar major depression was successfully treated without adverse effects. This case strengthens the impression that Anorgasmia associated with SSRIs is related primarily to the serotonine reuptake inhibition and not to various receptor bindings of different compounds.
Rezaei E Ghalechi - One of the best experts on this subject based on the ideXlab platform.
-
318 the study of causes of the psychological and pharmacological Anorgasmia in affected women in ardabil
European Psychiatry, 2013Co-Authors: Rezaei E Ghalechi, R. Kazemi, M. Pirzadeh, N. SalehiAbstract:Introduction Women's mental health is important factor for life of societies. Objectives Many factors affect orgasmic function, age, education, job, folklore (taboos) religious beliefs, drugs, psychological disorders and gynecological surgery. Aims Our main goal was the study of causes of the psychological and pharmacological of Anorgasmia in affected women in Ardabil. Methods The present study is a descriptive-cross sectional one. a total of 500 married women were selected and they completed the demographic and female sexual function index (FSFI) questionnarie.orgasm was assessed according to the relevant questions in the FSFI questionnaire.122 women were anorgasmic and they completed the SCL-90 questionnaire. The data were analyzed using the statistical software SPSS and the descriptive statistics (frequency-percent) and the deductive statistics (Correlation-t test). P value Results The prevalence of Anorgasmia among women in Ardabil was 24.4% and the average age of th anorgasmic women was 31.1%. The relation between the obsession -compulsion disorder and the Anorgasmia with P=0.000 was meaningful. The relation of depression with P=0.91 and using the SSRI drugs with P=0.28 and using the three cyclic anti-depression drugs with P=0.09 and using the ACE-I drugs with P=0.63 with the Anorgasmia wasn’t meaningful. Conclusion The prevalence of Anorgasmia in Ardabil women is at its high level and psychological factors influence this disorder so the diagnosis of this disorder and control of effective factors will help reducing of family fade and its impacts on society.
Morten Frisch - One of the best experts on this subject based on the ideXlab platform.
-
sexual dysfunctions and difficulties in denmark prevalence and associated sociodemographic factors
Archives of Sexual Behavior, 2011Co-Authors: Birgitte S. Christensen, Morten Grønbæk, Bo V. Pedersen, Christian Graugaard, Merete Osler, Morten FrischAbstract:Sexual dysfunctions and difficulties are common experiences that may impact importantly on the perceived quality of life, but prevalence estimates are highly sensitive to the definitions used. We used questionnaire data for 4415 sexually active Danes aged 16–95 years who participated in a national health and morbidity survey in 2005 to estimate the prevalence of sexual dysfunctions and difficulties and to identify associated sociodemographic factors. Overall, 11% (95% CI, 10–13%) of men and 11% (10–13%) of women reported at least one sexual dysfunction (i.e., a frequent sexual difficulty that was perceived as a problem) in the last year, while another 68% (66–70%) of men and 69% (67–71%) of women reported infrequent or less severe sexual difficulties. Estimated overall frequencies of sexual dysfunctions among men were: premature ejaculation (7%), erectile dysfunction (5%), Anorgasmia (2%), and dyspareunia (0.1%); among women: lubrication insufficiency (7%), Anorgasmia (6%), dyspareunia (3%), and vaginismus (0.4%). Highest frequencies of sexual dysfunction were seen in men above age 60 years and women below age 30 years or above age 50 years. In logistic regression analysis, indicators of economic hardship in the family were positively associated with sexual dysfunctions, notably among women. In conclusion, while a majority of sexually active adults in Denmark experience sexual difficulties with their partner once in a while, approximately one in nine suffer from frequent sexual difficulties that constitute a threat to their well-being. Sexual dysfunctions seem to be more common among persons who experience economic hardship in the family.
-
Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark.
The Journal of Sexual Medicine, 2011Co-Authors: Birgitte S. Christensen, Morten Grønbæk, Bo V. Pedersen, Christian Graugaard, Morten FrischAbstract:ABSTRACT Introduction Studies have linked obesity, a sedentary lifestyle, and tobacco smoking to erectile dysfunction, but the evidence linking unhealthy lifestyle factors to other sexual dysfunctions or to sexual inactivity is conflicting. Aim To examine associations between unhealthy lifestyle factors and sexual inactivity with a partner and four specific sexual dysfunctions in each sex. Methods We used nationally representative survey data from 5,552 Danish men and women aged 16–97 years in 2005. Cross‐sectional associations of lifestyle factors with sexual inactivity and sexual dysfunctions were estimated by logistic regression‐derived, confounder‐adjusted odds ratios (ORs). Main Outcome Measures We calculated ORs for sexual inactivity with a partner and for sexual dysfunction and sexual difficulties overall in both sexes, for erectile dysfunction, Anorgasmia, premature ejaculation, and dyspareunia in men, and for lubrication insufficiency, Anorgasmia, dyspareunia, and vaginismus in women. Results Obesity (body mass index [BMI]≥30 kg/m 2 ) or a substantially increased waist circumference (men ≥102 cm; women ≥88 cm), physical inactivity, and, among women, tobacco smoking were each significantly associated with sexual inactivity in the last year. Among sexually active men, both underweight (BMI 2 ) and obesity, a substantially increased waist circumference, physical inactivity in leisure time, high alcohol consumption (>21 alcoholic beverages/week), tobacco smoking, and use of hard drugs were each significantly positively associated with one or more sexual dysfunctions (ORs between 1.71 and 22.0). Among sexually active women, the only significant positive association between an unhealthy lifestyle factor and sexual dysfunction was between hashish use and Anorgasmia (OR 2.85). Conclusion In both sexes, several unhealthy lifestyle factors were associated with sexual inactivity with a partner in the last year. Additionally, among sexually active participants, men with unhealthy lifestyles were significantly more likely to experience sexual dysfunctions. Considering the importance of a good sex life, our findings may be useful in attempts to promote healthier lifestyles. Christensen BS, Gronbaek M, Pedersen BV, Graugaard C, and Frisch M. Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark. J Sex Med 2011;8:1903–1916.
